Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

BACKGROUND: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Pharm Policy Pract
Hoofdauteurs: Årdal, Christine, Baraldi, Enrico, Theuretzbacher, Ursula, Outterson, Kevin, Plahte, Jens, Ciabuschi, Francesco, Røttingen, John-Arne
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2018
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885303/
https://ncbi.nlm.nih.gov/pubmed/29632669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-018-0135-0
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items